Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Roivant Sciences Ltd (ROIV)

433 + Investors. Track Smart Money conviction in ROIV. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +37
Streak
2Q ▲
Buyers last Q
59%

Smart Money Signals — ROIV

Based on 435 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added ROIV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
435 hedge funds hold ROIV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +39% more funds vs a year ago

fund count last 6Q
+123 new funds entered over the past year (+39% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 59% buying

258 buying181 selling
Last quarter: 258 funds bought or added vs 181 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-21 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 64 → 62 → 108 → 87. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 36% long-term, 36% new

■ 36% conviction (2yr+) ■ 28% medium ■ 36% new
Of the 435 current holders: 156 (36%) held >2 years, 123 held 1–2 years, and 156 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +29% but shares only +3% — price-driven

Value
+29%
Shares
+2%
Last quarter: the total dollar value of institutional holdings rose +29%, but actual share count only changed +3%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

62 → 64 → 62 → 108 → 87 new funds/Q
New funds entering each quarter: 64 → 62 → 108 → 87. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 40% veterans vs 38% newcomers

■ 40% veterans ■ 22% 1-2yr ■ 38% new
Entry-cohort mix of 454 holders: 182 (40%) are 2+ year veterans, 100 entered 1–2 years ago, and 172 (38%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 49% AUM from top-100 funds

49% from top-100 AUM funds
56 of 432 holders are among the 100 largest funds by AUM, controlling 49% of total institutional value in ROIV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ROIV

In 2026 Q1, 258 hedge funds were net buyers of ROIV (87 opened a new position, 171 added to an existing one), while 181 reduced or exited (131 trimmed, 50 sold completely) — a 59% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 49% of total institutional value in ROIV is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +37 funds (more new holders than closures). Total institutional holders: 435.

Hedge Fund Ownership: ROIV

How many hedge funds hold ROIV — quarterly history vs. share price
Quarterly hedge fund ownership of ROIV vs. share price

Market Analysis: ROIV

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ROIV

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Roivant Sciences Ltd (ROIV) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ROIV has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
ROIV
+12.6%
XLV
+2.1%

ROIV outperformed XLV by +10.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
ROIV
+6.5%
XLV
+3.2%

Since the filing became public, ROIV outperformed XLV by +3.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

37 top-rated funds 9 high-conviction
Consensus
6.9
/ 10
breadth
×
Elite
5.6
/ 10
conviction
Hedge Fund Positioning: ROIV
433 + Investors

Track Smart Money conviction in ROIV. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 433 398 8.79%
13F Shares 530M 517M 2.52%
Total Value $14.41B $11.13B 29.44%
New Positions 86 108 -22
Increased Positions 165 150 +15
Closed Positions 51 48 +3
Reduced Positions 130 97 +33
Total Calls 10 13 -23.08%
Total Puts 12 10 20.0%
PUT/CALL Ratio 1.2 0.77 Neutral

Statistics: ROIV

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

433 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ROIV. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ROIV holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 QVT Financial LP 51.04% 25,161,237 $697.0M
2 Patient Square Capital LP 40.13% 8,166,047 $226.2M
3 Whitefort Capital Management, LP 11.59% 1,419,000 $39.3M
4 Davern Capital Partners, LP 6.64% 873,398 $24.2M
5 ADAR1 Capital Management, LLC 5.36% 3,285,906 $91.0M
6 BlackBarn Capital Partners LP 5.09% 2,285,117 $63.3M
7 Darwin Global Management, Ltd. 4.76% 6,797,300 $179.5M
8 Perceptive Advisors LLC 4.49% 8,285,461 $229.5M
9 Penn Davis Mcfarland Inc 4.32% 1,592,623 $44.1M
10 Affinity Asset Advisors, LLC 4.01% 2,800,000 $77.6M
11 First Turn Management, LLC 3.68% 1,190,118 $33.0M
12 Two Seas Capital LP 3.61% 9,328,291 $258.4M
13 Parkside Financial Bank & Trust 2.82% 1,329,164 $36.8M
14 Integral Health Asset Management, LLC 2.65% 2,000,000 $55.4M
15 Stempoint Capital LP 2.08% 385,800 $10.7M
16 Dorsey Wright & Associates 1.98% 577,147 $16.0M
17 Sandro Wealth Management LLC 1.98% 89,292 $2.5M
18 DME Capital Management, LP 1.87% 2,152,669 $59.6M
19 Diadema Partners LP 1.58% 335,800 $9.3M
20 Farallon Capital Management LLC 1.53% 9,675,000 $268.0M
21 Rubric Capital Management LP 1.47% 5,000,000 $138.5M
22 AlphaCentric Advisors LLC 1.32% 47,667 $1.3M
23 Peak Financial Advisors LLC 1.30% 105,893 $2.9M
24 Seven Fleet Capital Management LP 1.13% 128,168 $3.6M
25 Cormorant Asset Management, LP 1.04% 750,000 $20.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Roivant Sciences Ltd (ROIV)

What does the Smart Money Trend signal show for ROIV?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added ROIV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ROIV?

Slight buying edge — 59% buying: Last quarter: 258 funds bought or added vs 181 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ROIV holders?

Elite ownership — 49% AUM from top-100 funds: 56 of 432 holders are among the 100 largest funds by AUM, controlling 49% of total institutional value in ROIV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ROIV?

Mixed — 36% long-term, 36% new: Of the 435 current holders: 156 (36%) held >2 years, 123 held 1–2 years, and 156 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Roivant Sciences Ltd (ROIV) following the 2026 Q1 hedge fund 13F filings?

As of today, ROIV has moved +6.5% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of +3.3%. Since the quarter end (March 31, 2026), ROIV has gained +12.6% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →